Cite
HARVARD Citation
Suzuki, K. et al. (n.d.). Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone. Leukemia & lymphoma. 54 (11), pp. 2412-2417. [Online].